Anticitrullinated protein/peptide antibodies and rheumatoid factors: Two distinct autoantibody systems

Arthritis Research and Therapy

Volumn 11, Issue 5, 2009, Pages

  Valesini, Guido ^a   Alessandri, Cristiano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; PEPTIDE ANTIBODY; RHEUMATOID FACTOR; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; CITRULLINE; IMMUNOGLOBULIN M;

ACUTE PHASE RESPONSE; ANTIBODY TITER; DIAGNOSTIC ACCURACY; DISEASE MARKER; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; BLOOD; IMMUNOLOGY; NOTE;

ACUTE-PHASE REACTION; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; CITRULLINE; HUMANS; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

EID: 75649133949     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2786     Document Type: Editorial

References (13)

1. Ursum J, Bos WH, Stadt RJ, Dijkmans BAC, van Schaardenburg D. Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoanti-body systems. A cohort study. Arthritis Res Ther 2009, 11:R75. 2714121, 19460147, 10.1186/ar2704.
2. Rönnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005, 64:1744-1749. 1755292, 15843452, 10.1136/ard.2004.033571.
3. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S. Meta-analysis: diagnostic accuracy of anticyclicncitrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007, 146:797-808.
4. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006, 65:845-851. 1798205, 16606649, 10.1136/ard.2006.051391.
5. Vossenaar ER, Després N, Lapointe E, Heijden A, Lora M, Senshu T, van Venrooij WJ, Ménard HA. RA specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004, 6:R142-R150. 400433, 15059278, 10.1186/ar1149.
6. Spadaro A, Riccieri V, Scrivo R, Alessandri C, Valesini G. Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum 2006, 55:681-682. 10.1002/art.22113, 16874773.
7. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006, 116:961-973. 1421345, 16585962, 10.1172/JCI25422.
8. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, Spencer J, Pitzalis C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009, 6:e1. 2621263, 19143467, 10.1371/journal.pmed.0060001.
9. Helmvan Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006, 54:1117-1121. 10.1002/art.21739, 16572446.
10. Nielen MM, van Schaardenburg D, Reesink HW, Stadt RJ, Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386. 10.1002/art.20018, 14872479.
11. Li W, Wang M, Irigoyen P, Gregersen PK. Inferring causal relationships among intermediate phenotypes and biomarkers: a case study of rheumatoid arthritis. Bioinformatics 2006, 22:1503-1507. 10.1093/bioinformatics/btl100, 16551663.
12. Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW. Comparison of threshold cut-points and continuous measures of anti-CCP antibodies in predicting future RA. J Rheumatol 2009, 36:706-711. 10.3899/jrheum.080895, 19228654.
13. Nowak UM, Newkirk MM. Rheumatoid factors: good or bad for you?. Int Arch Allergy Immunol 2005, 138:180-188. 10.1159/000088794, 16210858.